Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2025
Total Assets: $208.16B
Liabilities Breakdown FY2025
Total Liabilities: $121.39B
Asset Breakdown
Total Assets: $208.16B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.14B | 0.5% |
| Accounts Receivable | $11.87B | 5.7% |
| Inventory | $10.65B | 5.1% |
| Property, Plant & Equipment | $19.32B | 9.3% |
| Goodwill | $71.26B | 34.2% |
| Intangible Assets | $53.73B | 25.8% |
| Other Assets | $40.18B | 19.3% |
Liabilities Breakdown
Total Liabilities: $121.39B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.24B | 4.3% |
| Long-Term Debt | $61.64B | 50.8% |
| Other Liabilities | $54.50B | 44.9% |